Диссертация (1140051), страница 13
Текст из файла (страница 13)
– 2012. – Vol. 44, №01. – P. 74-94.67.Dominguez-Munoz,gastrointestinalJ.E.motility,EffectofpancreaticHelicobactersecretionandpyloriinfectionhormonereleaseoninasymptomatic humans / J.E. Dominguez-Munoz [et al.] // Scand. J. Gastroenterol.– 2001. – Vol. 36. – P.
1141-1147.68.Dworakowska, D. Repeated colonoscopic screening of patients with acromegaly:15-year experience identifies those at risk of new colonic neoplasia and allowsfor effective screening guidelines / D. Dworakowska [et al.] // Eur J Endocrinol. –2010. – Vol 163(1). – P. 21-28.69.Etxabe, J. Acromegaly: an epidemilogical study / J. Etxabe [et al.] // J EndocrinolInvest. 1993;16(3):181–7. doi: 10.1007/BF03344942.8970.Forman, D. Helicobacter pylori and gastric cancer / D.
Forman [et al.] // Scand. J.Gastroenterol. Suppl. – 1996. – Vol. 214. – P. 31-33.71.Fuchs, C.S. Gastric carcinoma / C.S. Fuchs [et al.] // N. Engl. J. Med. – 1995. –Vol. 6. – № 333(1). – P. 32- 41.72.Fukao, A. The evaluation of screening for gastric cancer in Miyagi Prefecture,Japan: a population-based case-control study / A. Fukao [et al.] // Int. J.
Cancer. –1995. – Vol. 3. – № 60(1). – P. 45-48.73.Giustina, A. Expert consensus document: A consensus on the medical treatmentof acromegaly / A. Giustina [et al.] // Nat. Rev. Endocrinol. – 2014. – № 10(4). –Р. 243-248 .74.Halvorsen, R.A. Diagnosis and staging of gastric cancer / R.A. Halvorsen [et al.]// Semin. Oncol.
– 1996. – Vol. 23, № 3. – P. 325-33575.Hamiton, S.R. Patology and Genetics of tumours of the Digestive System / S.R.Hamiton, A. Lauri. – Lyon: Altonen IARS Press, 2000.76.Hanazaki, K. Surgical treatment of gastric cancer detected by mass screening / K.Hanazaki [et al.] // Hepatogastroenterology. – 1997. – Vol. 44, № 16. – P. 11261132.77.Hassan, H.A. Changing trends in gastric carcinoma at a university medical center:a twelve-year retrospective analysis / H.A. Hassan [et al.] // J.
Clin.Gastroenterol. – 2001. – Vol. 32, № 1. – P. 37-40.78.Holdaway, I.M. A meta-analysis of the eff ect of lowering serum levels of GHand IGF-I on mortality in acromegaly / I.M. Holdaway [et al.] // Eur JEndocrinol. – 2008. – № 159. – Р. 89-95.79.Holdaway, I.M. Epidemiology of acromegaly / I.M. Holdaway, C Rajasoorya. //Pituitary. – 1999. – № 2(1).
– Р. 29-41.80.Holdaway, I.M. Factors infl uencing mortality in acromegaly / I.M. Holdaway [etal.] // J Clin Endocrinol Metab. – 2004. – Vol. 89, № 2. – P. 667-674.81.Hu, P.J. Helicobacter pylori associated with a high prevalence of duodenal ulcerdisease and a low prevalence of gastric cancer in a developing nation / P.J. Hu [etal.] // Gut. – 1995. – Vol. 36, № 2. P. 198-202.9082.Hunt, R.H. World Gastroenterology Organization (WGO-OMGE) practiceguideline: helicobacter pylori in developing countries / R.H. Hunt [et al.] //Chinese journal of gastroenterology-beijing.
– 2007. – № 12(1). – Р. 40.83.Imrie, C. Is Helicobacter pylori infection in childhood a risk factor for gastriccancer? / C. Imrie [et al.] // Pediatrics. – 2001. – Vol. 107, № 2. – P. 373-380.84.Jones, J.I. Insulin-like growth factors and their binding proteins: biologicalactions / J.I. Jones, D.R. Clemmons // Endocr Rev. – 1995. – № 16. – Р. 334.85.Kaise, M.
Magnifying endoscopy combined with narrow-band imaging fordifferential diagnosis of superficial depressed gastric lesions / M. Kaise [et al.] //Endoscopy. – 2009. – Vol. 41, № 4. – P. 310-315.86.Kato, K. Duodenal adenocarcinoma with neuroendocrine features in a patientwith acromegaly and thyroid papillary adenocarcinoma: a unique combination ofendocrine neoplasia / K. Kato [et al.] // Endocr J.
– 2012. – № 59(9). – Р. 791796.87.Katznelson, L. AACE acromegaly guidelines task forse, RECE Medicalguidelines for clinical practice for the diagnosis and treatment of acromegaly / L.Katznelson [et al.] // Endocr. Pract. – 2011. – Vol. 17, №. 4. – Р. 636-646.88.Katznelson, L. Acromegaly: an endocrine society clinical practice guideline / L.Katznelson [et al.] // J. Clin. Endocrinol. Metab. – 2014. – № 99(11). – Р. 393339351.89.Kawahara, Y. Novel chromoendoscopic method using an acetic acidindigocarmine mixture for diagnostic accuracy in delineating the margin of earlygastric cancers / Y.
Kawahara [et al.] // Dig. Endosc. – 2009. – № 21. – P. 14-19.90.Kimmell, K.T. Multi-modal management of acromegaly: a value perspective /K.T. Kimmell [et al.] // Pituitary. – 2015. – № 18(5). – Р. 658-665.91.Klein, I. Colonic polyps in patients with acromegaly / I. Klein [et al.] // AnnIntern Med. -1982. – № 97(1). – Р.
27-30.92.Kocher, H.M. Epidemiological study of oesophageal and gastric cancer in southeast England / H.M. Kocher [et al.] // Br. J. Surg. – 2001. – Vol. 88, № 9. – P.1249-1257.9193.Konturek, P.C. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2,PPAR gamma and impaired apoptosis in gastric carcinogenesis / P.C. Konturek[et al.] // Med Sci Monit. 2003. – Vol.
9(7). – Р. SR 53-66.94.Kurimoto, M. The prevalence of benign and malignant tumors in patients withacromegaly at a single institute / M. Kurimoto [et al.] // Endocr J. – 2008.- №55(1). – Р. 67-71.95.Lee, K.M. Effect of Helicobacter pylori on gastric epithelial cell kinetics andexpression of apoptosis-related proteins ingastric carcinogenesis / К.М. Lee [etal.] // Korean J Gastroenterol. – 2003. – Vol. 42(1). – P.
129.96.Leng, S.L. Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-IIinduced but not basal proliferation and adhesion of LIM 1215 colon cancer cells /S.L. Leng, K.S. Leeding, R.H. Whitehead [et al.] // Mol. Cell Endocrinol. – 2001.– Vol.
174. – P. 121-127.97.LeRoith, D Insulin-like growth factors / D. LeRoith // Ann NY Acad Sci. – 1993.– № 692. – Р. 1-9. 1398.LeRoith, D. Insulin-like growth factors / D. LeRoith // N Engl J Med. – 1997. –№ 336. – Р. 633-640.99.LeRoith, D. Molecularand cellular aspects of the insulin-like growth factor Ireceptor / D. LeRoith, H. Werner, D. Beitner-Johnson, C.T. RobertsJr // EndocrRev. – 1995. – № 16. – Р. 143-163.100. LeRoith, D.
Regulation of proliferation and apoptosis by the insulin-like growthfactor I receptor / D. LeRoith // Growth Horm IGF Res. – 2000. – № 1. – Р. 1213.101. Loeper, S., Ezzat, S. Acromegaly: re-thinking the cancer risk / S. Loeper, S. Ezzat// Rev Endocr Metab Disord. – 2008. – № 9(1).
– Р. 41-58.102. Malfertheiner, Р. Management of Helicobacter pylori infection – the MaastrichtV/Florence Consensus Report / P. Malfertheiner [et al.] // Gut. – 2017. – Vol. 66(1). – P. 6-30.92103. Matano, Y. Risk of colorectal neoplasm in patients with acromegaly and itsrelationship with serum growth hormone levels [et al.] / Y. Matano // Am JGastroenterol.
– 2005. – № 100(5). – Р. 1154-1160.104. Mehlmed, S. Williams Textbook of Endocrinology / S. Mehlmed. – 12th edition,Philadelphia, 2011. – Р. 440-475.105. Melmed, S. A consensus on the diagnosis and treatment of acromegalycomplications. / S. Melmed [et al.] // Pituitary. – 2013. – № 16(3). – Р. 294-302.106. Melmed, S. Clinical perspective: acromegaly and cancer: not a problem? / S.Melmed // The Journal of Clinical Endocrinology & Metabolism.
– 2001. – Vol.86, №. 7. – P. 2929-2934.107. Mercado, M. Successful mortality reduction and control of comorbidities inpatients with acromegaly followed at a highly specialized multidisciplinary clinic/ M. Mercado, B. Gonzalez, G. Vargas. [et al.] // J Clin Endocrinol Metab. –2014. – № 99(12).
– Р. 4438-4446.108. Mestron, A. Epidemiology, clinical characteristics, outcome, morbidity andmortality in acromegaly based on the Spanish Acromegaly Registry / А. Mestron[et al.] // Eur J Endocrinol. – 2004. – № 151. – Р. 439-446.109. Moayyedi, P.M. ACG and CAG Clinical Guideline: Management of Dyspepsia /P.M. Moayyedi [et al.] // Am J Gastroenterol. – 2017. – № 112(7). – Р. 988-1013.110.
Mustacchi, P. Occurrence of cancer in acromegaly and in hypopituitarism / P.Mustacchi, M.B. Shimkin // Cancer. – 1957. – № 10(1). – Р. 100-104.111. Nabarro, J.D. Acromegaly / Nabarro JD. // Clin Endocrinol (Oxf). – 1987. – №26(4). – Р. 481-512.112. Ng, S.T. Growth hormone treatment induces mammary gland hyperplasia inaging primates / S.T. Ng // Nat Med. – 1997. – № 3.
– Р. 1141–1144.113. Onate-Ocana, L.F. Gastric cancer in Mexico / L.F. Onate-Ocana [et al.] // GastricCancer. – 2001. – Vol. 4, № 3. – P. 162-164.114. Pennisi, A.P. Reduced expression of insuline-like growth factor I receptors inMCF breast cancer cells leads to a more metastatic phenotype / A.P. Pennisi [etal.] // Cancer Res. – 2002. – Vol. 62. – P. 6529-6537.93115. Penta, R. Helicobacter pylori and gastric epithelial cells: from gastritis to cancerR.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
